Impact of the IL-17F, IL-23 and IL-23R on susceptibility and phenotype of systemic lupus erythematosus

References

• Yu, B., M. Guan, Y. Peng, et al. 2011. Copy number variations of interleukin-17F, interleukin-21, and interleukin-22 are associated with systemic lupus erythematosus. Arthritis Rheum. 63: 3487–3492
   PubMed Web of Science ®Google Scholar
• Vincent, F. B., M. Northcott, A. Hoi, et al. 2013. Clinical associations of serum interlukin-17 in systemic lupus erythematosus. Arthritis Res. Ther. 15: R97
   PubMed Web of Science ®Google Scholar
• Noack, M., and P. Miossec. 2014. Th17 and regulatory T cell balance in autoimmune and inflammatory diseases. Autoimmun. Rev. 13:668–677
   PubMed Web of Science ®Google Scholar
• Yang, J., X. Yang, H. Zou, et al. 2011. Recovery of the immune balance between Th17 and regulatory T cells as a treatment for systemic lupus erythematosus. Rheumatology. 10:1366–1372
   Web of Science ®Google Scholar
• McCarthy, E. M., S. Smith, R. Z. Lee, et al. 2014. The association of cytokines with disease activity and damage score in systemic lupus erythematosus patients. Rheumatology. 53: 1586–1594
   PubMed Web of Science ®Google Scholar
• Tiffin, N., A. Adeyemo, and I. Okpechi. 2013. A diverse array of genetic factors contributes to the pathogenesis of systemic lupus erythematosus. Orphanet. J. Rare Dis. 8:2
   PubMed Web of Science ®Google Scholar
• Munroe, M. E., and J. A. James. 2015. Genetics of lupus nephritis: clinical implications. Semin. Nephrol. 35: 396–409
   PubMed Web of Science ®Google Scholar
• Relle, M., J. Weinmann-Menke, E. Scorletti, L. et al. 2015. Genetics and novel aspects of therapies in systemic lupus erythematosus. Autoimmun. Rev. 14: 1005–1018
   PubMed Web of Science ®Google Scholar
• Shi, Y. Y., and L. He. 2005. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 15: 97–98
   PubMed Web of Science ®Google Scholar
• Li, Z., Z. Zhang, Z. He, et al. 2009. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn). Cell Res. 19: 519–523
   PubMed Web of Science ®Google Scholar
• Lindqvist, A. K., and M.E. Alarcón-Riquelme. 1999. The genetics of systemic lupus erythematosus. Scand. J. Immunol. 50: 562–571
   PubMed Web of Science ®Google Scholar
• Reveille, J. D. 2005. Genetic studies in the rheumatic diseases: present status and implications for the future. J. Rheumatol. Suppl. 72: 10–13
   PubMedGoogle Scholar
• Ghodke-Puranik, Y., and T. B. Niewold. 2015. Immunogenetics of systemic lupus erythematosus: a comprehensive review. J. Autoimmun. 64: 125–136
   PubMed Web of Science ®Google Scholar
• Hammad, A., Y. M. Mosaad, E. M. Hammad, et al. 2015. Interleukin-17A rs2275913, Interleukin-17F rs763780 and rs2397084 gene polymorphisms as possible risk factors in Juvenile lupus and lupus related nephritis. Autoimmunity. 30: 1–10
   Google Scholar
• Kim, H. S., I. Kim, J. O. Kim, et al. 2009. No association between interleukin 23 receptor gene polymorphisms and systemic lupus erythematosus. Rheumatol. Int. 30: 33–38
   PubMed Web of Science ®Google Scholar
• Chen, G. M., C. C. Feng, Q. L. Ye, et al. 2013. Lack of association between IL-23R gene polymorphisms and systemic lupus erythematosus in a Chinese population. Inflamm. Res. 62: 791–795
   PubMed Web of Science ®Google Scholar
• Safrany, E., R. Hobor, L. Jakab, et al. 2010. Interleukin-23 receptor gene variants in Hungarian systemic lupus erythematosus patients. Inflamm. Res. 59: 159–164
   PubMed Web of Science ®Google Scholar
• Schanez, E., B. Rueda, J. L. Callejas, et al. 2007. Analysis of interleukin-23 receptor (IL23R) gene polymorphisms in systemic lupus erythematosus. Tissue Antigens. 70: 233–237
   PubMedGoogle Scholar
• Li, Y., W. B. Liang, C. Li, et al. 2010. The association between interleukin-23 receptor gene polymorphisms and systemic lupus erythematosus. DNA Cell Biol. 29: 79–82
   PubMed Web of Science ®Google Scholar
• Langrish, C. L., Y. Chen, W. M. Blumenschein, et al. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201: 233–240
   PubMed Web of Science ®Google Scholar
• Hue, S., P. Ajern, S. Buonocore, et al. 2006. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J. Exp. Med. 203: 2473–2483
   PubMed Web of Science ®Google Scholar
• Sato, K., A. Suematsu, K. Okamoto, et al. 2006. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 203: 2673–2682
   PubMed Web of Science ®Google Scholar
• Izcue, A., S. Hue, S. Buonocore, et al. 2008. Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis. Immunity. 28: 559–570
   PubMed Web of Science ®Google Scholar
• Cua, D. J., J. Sherlock, Y. Chen, et al. 2003. Sedgwick. Inerleukin-23 tarher than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 421: 706–708
   PubMed Web of Science ®Google Scholar
• Iwakura, Y., and H. Ishigame. 2006. The IL-23 / IL-17 axis in inflammation. J Clin Invest. 116: 1218–1222
   PubMed Web of Science ®Google Scholar
• Cheung, P. F., C. K. Wong, and C. W. Lam. 2008. Molecular mechanisms of cytokine and chemokine release from eosinophils activated by IL-17A, IL-17F and IL-23: implication for Th17 lymphocytes-mediated allergic inflammation. J. Immunol. 180: 5625–5635
   PubMed Web of Science ®Google Scholar
• Kim, H. R., H. S. Kim, M. K. Park, et al. 2007. The clinical role of IL-23p19 in patients with rheumatoid arthritis. Scand. J. Rheumatol. 36: 259–264
   PubMed Web of Science ®Google Scholar
• Nistala, K., and L. R. Wedderburn. 2009. Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis. Rheumatology. 48: 602–606
   PubMed Web of Science ®Google Scholar
• Kim, H. R., M. L. Cho, K. W. Kim, et al. 2007. Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by Il-17 through PI3-kinase, NF-jB and p38 MAPK-dependent signaling pathways. Rheumatology. 46: 57–64
   PubMed Web of Science ®Google Scholar
• Kwan, B. C., L. S. Tam, K. B. Lai, et al. 2009. The gene expression of type 17 T-helper cell-related cytokines in the urinary sediment of patients with systemic lupus erythematosus. Rheumatology (Oxford). 48: 1491–1497
   PubMed Web of Science ®Google Scholar
• Talaat, R. M., S. F. Mohamed, I. H. Bassyouni, and A. A. Raouf. 2015. Th1/Th2/Th17/treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: correlation with disease activity. Cytokine. 72: 146–153
   PubMed Web of Science ®Google Scholar